Does TRIMETHOPRIM Cause Malignant neoplasm progression? 12 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Malignant neoplasm progression have been filed in association with TRIMETHOPRIM (Trimethoprim). This represents 0.4% of all adverse event reports for TRIMETHOPRIM.
12
Reports of Malignant neoplasm progression with TRIMETHOPRIM
0.4%
of all TRIMETHOPRIM reports
8
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TRIMETHOPRIM?
Of the 12 reports, 8 (66.7%) resulted in death, 4 (33.3%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIMETHOPRIM. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TRIMETHOPRIM Cause?
Headache (409)
Nausea (383)
Off label use (376)
Drug ineffective (368)
Malaise (346)
Swelling face (267)
Hypersensitivity (260)
Acute kidney injury (249)
Rash (235)
Drug intolerance (231)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TRIMETHOPRIM Alternatives Have Lower Malignant neoplasm progression Risk?
TRIMETHOPRIM vs TRIMIPRAMINE
TRIMETHOPRIM vs TRIPROLIDINE
TRIMETHOPRIM vs TRIPTORELIN
TRIMETHOPRIM vs TRISODIUM
TRIMETHOPRIM vs TROFINETIDE